NEWCASTLE UPON TYNE, England--(BUSINESS WIRE)--Nonlinear Dynamics Ltd, the company solving problems in proteomics, genomics, biomarker discovery and clinical diagnostics today announced that the National Cancer Research Institute (Tokyo, Japan) is successfully using Progenesis SameSpots as part of its biomarker discovery program
